Calvin Sternick

Stock Analyst at JP Morgan

(2.09)
# 2,827
Out of 4,868 analysts
19
Total ratings
46.15%
Success rate
6.66%
Average return

Stocks Rated by Calvin Sternick

U.S. Physical Therapy
Mar 19, 2025
Maintains: Overweight
Price Target: $120$110
Current: $73.79
Upside: +49.07%
Centene
Jul 10, 2024
Maintains: Neutral
Price Target: $85$80
Current: $55.15
Upside: +45.06%
PACS Group
May 6, 2024
Initiates: Overweight
Price Target: $27
Current: $13.30
Upside: +103.01%
Universal Health Services
Mar 13, 2024
Maintains: Neutral
Price Target: $144$182
Current: $171.24
Upside: +6.28%
Tenet Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $91$81
Current: $167.58
Upside: -51.66%
Molina Healthcare
Nov 17, 2023
Maintains: Overweight
Price Target: $367$392
Current: $295.34
Upside: +32.73%